Skip to main content
logo
Kestra Medical Technologies, Ltd. (KMTS)
NASDAQ: KMTS · Real-Time Price · USD
25.83
+0.71 (2.83%)
Sep 2, 2026, 11:22 AM EDT - Market open

KMTS Financials Overview

Millions USD. Fiscal year is May - Apr.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2021
Period EndingApr '26 Apr '26 Apr '25 Apr '24 Apr '23 Apr '21
Revenue
95.1395.1359.8227.817.63-
Revenue Growth
59.03%59.03%115.05%264.54%--
Gross Profit
48.8648.8624.210.36-10.65-
Operating Income
-134.74-134.74-106.38-85.06-80.42-32.71
Net Income
-131.61-131.61-126.14-100.84-86.74-34.1
Earnings Per Share
-2.43-2.43-5.13-5.07-819.76-322.29
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2021
Period EndingApr '26 Apr '26 Apr '25 Apr '24 Apr '23 Apr '21
Cash & Investments
196.43196.43237.68.2514.8124.34
Total Debt
46.7946.7944.3145.1739.1322.85
Net Cash (Debt)
149.64149.64193.28-36.92-24.321.49
Net Cash Growth
-22.58%-22.58%----71.85%
Net Cash Per Share
2.762.767.86-1.86-229.8914.11

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2021
Period EndingApr '26 Apr '26 Apr '25 Apr '24 Apr '23 Apr '21
Operating Cash Flow
-81.7-81.7-77.61-72.24-69.64-29.9
Capital Expenditures
-35.42-35.42-23.59-12.51-15.46-0.34
Free Cash Flow
-117.12-117.12-101.2-84.75-85.1-30.23
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2021
Period EndingApr '26 Apr '26 Apr '25 Apr '24 Apr '23 Apr '21
Gross Margin
51.37%51.37%40.48%1.30%-139.59%-
Operating Margin
-141.65%-141.65%-177.84%-305.83%-1054.01%-
Pretax Margin
-138.05%-138.05%-190.05%-338.30%-1103.84%-
Profit Margin
-138.36%-138.36%-210.88%-362.56%-1136.79%-
FCF Margin
-123.12%-123.12%-169.19%-304.70%-1115.37%-

Valuation
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2021
Period EndingSep '26 Apr '26 Apr '25 Apr '24 Apr '23 Apr '21
PS Ratio
15.4812.7220.65---